▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

QPharma Names Badal Shah as President of Neolytica, Recognizing His Position as a Founder

QPharma, a compliance and commercial services leader in the life sciences industry, is thrilled to announce Mr. Badal Shah, B.Pharm, M.B.S, as President of Neolytica, its healthcare analytics division...

Business Wire

MORRISTOWN, N.J.: QPharma, a compliance and commercial services leader in the life sciences industry, is thrilled to announce Mr. Badal Shah, B.Pharm, M.B.S, as President of Neolytica, its healthcare analytics division.

Mr. Shah spearheads the company's health analytics solutions i.e. Key Opinion Leader (KOL) mapping, Health Care Professional (HCP) targeting and Opioid Risk. His dedication, leadership, and vision have been instrumental in revolutionizing the industry through advanced sentiment analysis.

As President, Mr. Shah will be solely responsible for Neolytica’s growth and operations. He aims to harness generative AI to pioneer groundbreaking solutions that address industry gaps, including Next Best Action (NBA), Omnichannel Solutions, Market Access stakeholder mapping. Moreover, he will spearhead strategic initiatives for extending Neolytica's global presence in regions such as Europe, Latin America, and Asia.

Reno Amadori, QPharma CEO, mentioned "We take great pride in announcing Mr. Badal Shah as the Founder & President of Neolytica. His contributions and exemplary leadership have been instrumental in establishing our leadership within the healthcare analytics industry. We are certain Badal will perpetuate the tremendous growth Neolytica has consistently achieved and further Neolytica leadership in healthcare analytics."

Mr. Shah, a distinguished pharmacist specializing in Drug Discovery and Development, has global recognition through numerous accolades and awards. He also serves as an Industrial Advisory Board Member at the esteemed Rutgers University.

Mr. Shah remarked, "Honored to be recognized as a founder and assume the role of President. We are poised to introduce innovative solutions through generative AI to transform both medical and commercial pharma communication to HCPs. I look forward to expanding our footprint globally and in other sectors like Medical Devices and Clinical Trials."

Mr. Shah revealed exciting news about Neolytica's upcoming launch of Ti Expert® 2.0, the most advanced Expert mapping solution, scheduled for early next year.

About QPharma and Neolytica:

Founded in 1994, QPharma is the industry leader in cloud-based software and services to the life sciences industry. The company’s Commercial Services division provides solutions that include sample management and distribution, product launch management, LMS.

Neolytica, a QPharma division, brings global experience and cutting-edge technology products that leverage data science and AI for KOL mapping/HCP targeting for pharmaceutical and biotech companies. It was recognized as the 100 most promising companies in 2022 by Silicon magazine.

Contacts

Media
Patrick O’Hara
patrick.ohara@qpharmacorp.com

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Resecurity to Exhibit at DSEI Japan 2025, Showcasing AI-Driven Cybersecurity…

Resecurity, a U.S.-based leader in cyber threat intelligence and risk management solutions, is proud to announce its participation in DSEI Japan 2025,…

Generational Group Advises Elarasys Worldwide, LLC and IT Hardware Plus,…

Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Elarasys Worldwide,…

LICT Corporation Reports 2025 First Quarter Results

LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports financial results for the quarter ended March 31, 2025. Total revenues for the first…

BostonGene to Showcase its Multimodal AI Platform Advancing Drug Development…

BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced that six abstracts have been accepted at the 2025 ASCO…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!